[Toll-like receptor and acute leukemia complicated with infection - review].
Infection and antibiotic multidrug resistance have become the focal issue in clinical treatment of acute leukemia and will make anti-infection therapy facing to new challenge. Toll-like receptor (TLR) has been found a newly innate immunoreceptor. It is significant in immune response. Along with further investigation of TLR, infection and anti-infection immunity theory would gain a new breakthrough and play a guiding role in clinical treatment of acute leukemia complicated with infection. In this review, the progress in the research of TLR and its expression in acute leukemia complicated with infection were summarized.
Li
Xue-Qing
XQ
Department of Hematology, The Second Teaching Hospital of Shanxi Medical University, Taiyuan 030001, China.
Su
Li-Ping
LP
D000208:Acute Disease; D006801:Humans; D007239:Infections / Q000150:complications* / Q000276:immunology; D007938:Leukemia / Q000150:complications / Q000276:immunology* / Q000378:metabolism*; D051197:Toll-Like Receptor 4 / Q000276:immunology / Q000378:metabolism; D051193:Toll-Like Receptors / Q000276:immunology* / Q000378:metabolism
D051197:Toll-Like Receptor 4; D051193:Toll-Like Receptors